Profilo
Michael R.
Goldberg joined Theravance, Inc. as Vice President of Clinical Pharmacology in September 2005.
From 1988 to 2005, he was Senior Director of Safety/Clinical Risk Management and Safety Surveillance for Merck and worked at Eli Lilly in the Clinical Pharmacology Department.
Dr. Goldberg received his MD and PhD degrees from Tulane University, School of Medicine and completed his Clinical Pharmacology fellowship at the Vanderbilt University School of Medicine.
Precedenti posizioni note di Michael R. Goldberg
Società | Posizione | Fine |
---|---|---|
MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2005 |
INNOVIVA, INC. | Corporate Officer/Principal | - |
Formazione di Michael R. Goldberg
Tulane University (Louisiana) | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
INNOVIVA, INC. | Health Technology |
- Borsa valori
- Insiders
- Michael R. Goldberg